Mark G. Currie, President at Cyclerion Therapeutics, Inc. (CYCN), bought 270,107 shares at $14.81 ($4.0M) on 2019-04-02, disclosed to the SEC on 2019-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |